{
    "clinical_study": {
        "@rank": "72266", 
        "acronym": "RITE", 
        "arm_group": [
            {
                "arm_group_label": "PL2200 Aspirin Capsules", 
                "arm_group_type": "Experimental", 
                "description": "PL2200 Aspirin Capsules"
            }, 
            {
                "arm_group_label": "Enteric-coated aspirin caplets", 
                "arm_group_type": "Active Comparator", 
                "description": "Enteric-coated aspirin caplets"
            }
        ], 
        "brief_summary": {
            "textblock": "This study will determine if aspirin from PL2200, an investigational product, gets into the\n      blood stream as quickly as enteric coated aspirin, and to test whether PL2200 is able to\n      prevent blood clots as effectively as enteric coated aspirin, when administered to patients\n      with diabetes"
        }, 
        "brief_title": "Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated Aspirin in Diabetic Patients", 
        "condition": "Diabetes Mellitus, Type 2", 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 2"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Non-Insulin-Dependent Diabetes Mellitus\n\n          -  Adults 21 to 79 years, inclusive\n\n          -  Body mass index between 30 and 40 kg/m2, inclusive\n\n        Exclusion Criteria:\n\n          -  Currently prescribed aspirin or anti-coagulants\n\n          -  Contraindications to aspirin\n\n          -  Significant disease history or active disease other than Non-Insulin-Dependent\n             Diabetes Mellitus\n\n          -  Patient requires insulin"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "79 Years", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "56", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 6, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02008942", 
            "org_study_id": "PL-ASA-006"
        }, 
        "intervention": [
            {
                "arm_group_label": "PL2200 Aspirin Capsules", 
                "description": "325 mg aspirin; once per day for 10 days", 
                "intervention_name": "PL2200 Aspirin Capsules", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Enteric-coated aspirin caplets", 
                "description": "325 mg aspirin; once per day for 10 days", 
                "intervention_name": "Enteric-coated aspirin caplets", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Aspirin"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "January 8, 2014", 
        "location": [
            {
                "contact": {
                    "last_name": "Noris Peraita", 
                    "phone": "305-722-4440"
                }, 
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33143"
                    }, 
                    "name": "Miami Research Associates"
                }, 
                "investigator": {
                    "last_name": "Patricia Pardo, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Tammy Steuart", 
                    "phone": "913-410-2000"
                }, 
                "facility": {
                    "address": {
                        "city": "Lenexa", 
                        "country": "United States", 
                        "state": "Kansas", 
                        "zip": "66219"
                    }, 
                    "name": "PRA Clinical Pharmacology Center"
                }, 
                "investigator": {
                    "last_name": "Sandra K Willsie, DO, MA", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "recruitment@medpace.com", 
                    "last_name": "Recruitment", 
                    "phone": "866-872-2349"
                }, 
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45227"
                    }, 
                    "name": "Medpace Clinical Pharmacology"
                }, 
                "investigator": {
                    "last_name": "Lukasz Biernat, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Reliable Inhibition of Thrombocyte Activity: Comparison of PL2200 Aspirin Capsules, 325 mg and Enteric-Coated Aspirin (RITE Study)", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "United States: MidLands Independent Review Board", 
                "United States: Food and Drug Administration"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Serial measurements of aspirin anti-platelet activity will be collected over 11 days, and compared between groups, to allow a determination of pharmacodynamic (anti-platelet) bioequivalence between study drugs", 
            "measure": "Pharmacodynamic bioequivalence", 
            "safety_issue": "No", 
            "time_frame": "11 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02008942"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Serial measures of aspirin plasma levels will be collected over 2 days, and compared between groups, to allow a determination of pharmacokinetic bioequivalence between study drugs.", 
                "measure": "Pharmacokinetic bioequivalence", 
                "safety_issue": "No", 
                "time_frame": "2 days"
            }, 
            {
                "description": "Assessment and comparison of the incidence of adverse events between treatment groups; changes in clinical laboratory parameters from baseline and between treatment groups; and changes in vital signs from baseline and between treatment groups", 
                "measure": "Safety and tolerability", 
                "safety_issue": "Yes", 
                "time_frame": "11 days"
            }
        ], 
        "source": "PLx Pharma", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "PLx Pharma", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}